CEO Ron Squarer (Apr 2012–) | Founder Kevin Koch | |
 | ||
Stock price ARRY (NASDAQ) US$ 11.69 +0.19 (+1.65%)1 Mar, 4:00 PM GMT-5 - Disclaimer Headquarters Boulder, Colorado, United States | ||
Array BioPharma is a clinical stage publicly traded pharmaceutical company (NASDAQ:ARRY) that is in the NASDAQ Biotechnology Index and is worth over 990 million dollars.
Pipeline
As of 2016, Array BioPharma has a number of compounds in clinical development.
References
Array BioPharma Wikipedia(Text) CC BY-SA